<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01645943</url>
  </required_header>
  <id_info>
    <org_study_id>11/ 01595</org_study_id>
    <nct_id>NCT01645943</nct_id>
  </id_info>
  <brief_title>Invasive vs Conservative Strategies in Non-ST-elevation Acute Coronary Syndrome and Comorbidities</brief_title>
  <acronym>MOSCA</acronym>
  <official_title>Randomized Comparison Between Invasive and Conservative Strategies in Patients With Non-ST-segment Elevation Acute Coronary Syndrome and Comorbidities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Valencia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The guidelines of clinical practice, based on the randomized studies, recommend an invasive
      strategy in non-ST elevation acute coronary syndrome (NSTEACS). However, patients with
      comorbidities are excluded from the randomized studies and the observational registries
      showthat patients with comoribidities undergo fewer cardiac catheterizations. The aim is to
      investigate the benefit of the invasive strategy in patients with NSTEACS and comorbidities.

      Patients hospitalized with NSTEACS, older than 70 years and with significant comorbidities,
      will be included. The latter will be defined as at least 2 of the following: peripheral
      artery disease, cerebral vascular disease, dementia, chronic pulmonary disease, chronic renal
      failure and anemia. The included patients will be randomized to an invasive (routine coronary
      angiogram) or conservative (coronary angiogram only if recurrent or inducible ischemia)
      strategy. All patients will receive medical treatment according to current recommendations.

      The main outcome will be death, reinfarction or readmissions by heart cause at one-year
      follow-up. The hypothesis is that an invasive strategy will improve prognosis in patients
      with NSTEACS and comorbidities.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality, reinfarction or reasmission by cardiac cause</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days alive out of the hospital</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>In-hospital (average= 1 week)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal failure</measure>
    <time_frame>In-hospital (average= 1 week)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">109</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Conservative</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Coronary angiogram only if recurrent ischemia or peristent heart failure or inducible ischemia in predischarge stress test if perfomed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Invasive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Routine coronary angiogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angiogram</intervention_name>
    <description>Routine coronary angiogram and revascularization if indicated</description>
    <arm_group_label>Invasive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age =&gt;70 years old

          -  Angina chest pain

          -  Troponin elevation

          -  At least 2 of the following comorbidities: A) Documented peripheral artery disease.
             B)Renal filaure (GFR &lt;45 ml/min/m2). C) Neurological disease with permanent deficit.
             D) Dementia (Pfeiffer test). E) Chronic pulmonary disease (Gold&gt;2 or ambulatory oxigen
             therapy). Anemia (Hb =&lt;11 g/dl)

        Exclusion Criteria:

          -  Dynamic ST changes (=&gt;1 mm) in the initial ECG

          -  Prior known non-revascularizable coronay disease

          -  Concomitant heart disease different to coronary disease

          -  Life expentancy &lt; 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Sanchis, Full Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Valencia. University Clinic Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Pujol i Trias</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Rosell</name>
      <address>
        <city>Cartagena</city>
        <state>Murcia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopsital Clinic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Valle Hebrón</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario</name>
      <address>
        <city>Valencia</city>
        <zip>460140</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Sanchis J, Núñez E, Barrabés JA, Marín F, Consuegra-Sánchez L, Ventura S, Valero E, Roqué M, Bayés-Genís A, Del Blanco BG, Dégano I, Núñez J. Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction. Eur J Intern Med. 2016 Nov;35:89-94. doi: 10.1016/j.ejim.2016.07.003. Epub 2016 Aug 8.</citation>
    <PMID>27423981</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2012</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Valencia</investigator_affiliation>
    <investigator_full_name>Juan Sanchis</investigator_full_name>
    <investigator_title>Full Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Non-ST-elevation acute myocardial infarction</keyword>
  <keyword>Comorbidities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

